U.S. Markets close in 1 hr 55 mins

VIVUS, Inc. (VVUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.964-0.024 (-2.429%)
As of 2:05PM EDT. Market open.
People also watch
OREXARNAKERXAMRNXOMA
  • K
    Kevin
    Kevin
    The absurdity of resident spy kid Rupduche is that he continues to watch from the eaves believing he can spot a distressed long and continues to feed that BS to his boss. Even more absurd is his boss buys that BS. Most absurd is the belief that "THEY" can mask their manipulation with FLIMSY arguments like Qsyimia scribers should be reported...who says junk like that? Or that Q needs CVOT because the FDA said so 5 years ago while in the same breath disclose the number of Phen/Top scrips that go out with out the door without a REMS or CV post market look...how much more contrived can these jokers get?
  • R
    Rupdesh
    Rupdesh
    Please remember to identify and insult physicians who prescribe Qsymia rather than Phen or PhenTop. These quacks are either Uncaring, Lazy, Ignorant, or Cowardly. I would NOT recommend such an incompetent physician to anyone.
  • C
    Confidential Confidential
    Confidential Confidential
    In light of declining short interest, et. al, it looked like a great time to cover. So there! Long! ; )
  • N
    Nonc Lloyd
    Nonc Lloyd
    Hey fake mooky, go check the tire pressure in the Mack truck I carry my balls around in, and while you're at it reset the delisting clock on V you megimp. Picked up another load during this latest short covering episode. Manipulation at its best.
  • K
    Kevin
    Kevin
    Gilead pays 12B for 30M revenues Kite Pharma. 21st century T-cell therapy with CURATIVE potentials.

    Gene therapy is so 21 century. Makes me wonder what VVUS has cooking as it plans to bring on two more devo projects.
  • w
    web
    web
    Sammy the Mule.....Back to his Schizophrenic self. One of these days you will be yelling out the your were finally correct. Even though you have missed the boat since the first day that you supposedly purchased VVUS shares. everything VVUS has done over the past years has been "MATERIAL" and when VVUS makes its move higher it will be because of the compilation of all of these events. Your need for some one time "event" is just plain ignorant and quite frankly it is flat out stupid and very telling of the type of person that you are. You are the type of person who is constantly praying for a move and event rather than looking at the big picture of moving the company forward on a daily, weekly, monthly and yearly path. This would be the correct way to build a company, your hope is that VVUS finds a needle in the haystack and not grow as most other quality company's grow. Your ignorance is just over the top Sammy the Mule. This is why you have become a "MULE" Jack#$%$' moron. Your brain has been wiped clean by ruprecht.
  • K
    Kevin
    Kevin
    GAZOO'z smart watch just blew a spring and ARGILE pooped his kilt when he caught his bagpipe on the dollar store sigh.
  • m
    mooky
    mooky
    Market at record highs and VVUS at record lows take that limp Lloyd,web,luser,kevin.THE MOOKY KOOKY TWIST.
  • K
    Kevin
    Kevin
    Rupdish says, "The fund manager does a far superior job weeding out the nonsense." VVUS did a far better job wedding out the fund managers and protecting its' assets. Fischer had little or nothing to do with this as it all began in 2007. His only contribution will be redefining what is an acquiring person and setting a fund ownership to 4.9. Sometimes I think Gazoo is a little GREEN man because he's smoking something. He is now trying to plaster his renderings of my discussions WITH OTHERS, not him! He's still THE CYBER CREEP.
  • w
    web
    web
    YOU LIKE THAT SAMMY????? HeeHaw....HeeHaw...HeeHaw!
  • w
    web
    web
    Sammy the Mule.....Material Move Coming!!!!!! Watch the close!!!! HeeHaw....HeeHaw....HeeHaw!
  • S
    Samuel T
    Samuel T
    WebKevin(+) hypes what a rose Vvus is. Lets assume he is right. If he is right, why cant Vvus even get back to over a lousy buck?? Cant the professional fund managers see what WebKevin(+) clearly sees??? Apparently not but then why cant the rest of the market and retail see the Vvus through the same rose covered glasses that WebKevin(+) wears?? Golly Gee!!, I just cant figure it out, after all WebKevin(+) is NEVER wrong (at least in his own defective mind). Could it possibly be that Vvus is going to need a materially positive event to ever breathe some life into it???, such an event isn't necessary according to WK+. and I remind you that he is NEVER wrong (if you don't believe me, just ask him and he will loudly tell you he is omnipotent and infallible). That being said, I remain long because Vvus COULD still have a very bright future if some materially positive event does occur and/or we get favorable trial results for our new drug. Materially positive events might surface in the form of a continuing constant revenue stream for a Q or S deal, the acquiring of additional drugs that don't break our bank, a major brokerage firm coverage of Vvus with a strong buy recommendation, etc. etc. Until we see a materially positive event occur in Vvus, this stock is most unlikely to do much based on its performance for at least the last 3 years and its disingenuous management's debilitating effect on Vvus's credibility. I will now return control of this board back to WK so that after flaming me incessantly, he can resume his life's work of mindlessly pumping this stock.
  • K
    Kevin
    Kevin
    @Gazoo...."CERTAIN TRIGGERS"...unhinge QSYMIA into the hands of 3 of the biggest GENERIC makers on the planet as part of their much needed BRANDED portfolios. GGG's what could they be...hint...Seth mentioned one of them at the Wells Fargo conference.
  • w
    web
    web
    Short share are down over 1 million shares in the last 15 days. VVUS now down to about 5 million shares short.
  • U
    User
    User

    http://www.fiercebiotech.com/biotech/fda-commish-we-need-to-talk-about-drug-development-costs

    Sounds good Scott, but we do not need much of your time. We just need you to reconsider our CVOT.

    FDA commissioner: We need to talk about drug development costs | FierceBiotech
    New FDA Commissioner Scott Gottlieb wants to target drug development costs as yet another study asks how much it really costs to make a medicine.
    www.fiercebiotech.com
  • m
    mooky
    mooky
    Somebody help web he is trapped
    Imageshelgon
  • w
    wspencerv12
    wspencerv12
    1.50 by November buy now
  • R
    Rupdesh
    Rupdesh
    What I hear, given my lack of financial education, when Web and Kevin make (their) sense out of Vivus:

    ?So with the blessing of Karl Ikahn, Seth set up a Poison Pill scenerio based on levered debt and a restructuring of IKahn's bond load. Do you agree, Kevin?"

    Now THIS is what an educated, TRAINED fund manager hears from that same Web conversation:

    "Blah blah blah, Karl IKahn, Seth blah blah Poison Pill,--blah, blah, blah...Do you agree, Kevin?"
  • K
    Kevin
    Kevin
    More anecdotal BS from Gazoo...Who still refuses to ackowledge the difference between a NME and TREATMENT. His lack of knowledge is astounding! VVUS IP opened the door and VVUS Q REMS is still a factor...Where can I reference Mrs L's time in the public eye. Or is this just creative license? Citation please!
  • R
    RENDILL
    RENDILL
     19 at 4:30 PM

    InsiderForms

    $VVUS Director "Shaw Allan" just acquired 908 Shares (Tran Code - D, M) --- Insider Forms, iOS app